2-(2-噻吩基)苯甲酰氯 | 97677-81-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(2-噻吩基)苯甲酰氯
• 中文别名: 2-(2-噻吩)苯甲酰氯
• 英文名称: 2-(2'-chloroformylphenyl)thiophene
• 英文别名: 2-(thiophen-2-yl)benzoyl chloride；2-thiophen-2-ylbenzoyl chloride
• CAS: 97677-81-1
• 化学式: C₁₁H₇ClOS
• mdl: MFCD06797479
• 分子量: 222.695
• InChiKey: JVOVWZAGQKKACR-UHFFFAOYSA-N

物化性质

• 沸点：
  346.2±25.0 °C(Predicted)
• 密度：
  1.305±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  45.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  C
• 海关编码：
  2934999090

反应信息

• 作为反应物：
  描述：

  2-(2-噻吩基)苯甲酰氯 在 四氯化锡 作用下， 以 苯 为溶剂， 反应 0.5h， 以5.84 g的产率得到4H-茚并[1,2-B]噻吩-4-酮
  参考文献：
  名称：

  Quaterthiophenes with Terminal Indeno[1,2-b]thiophene Units as p-Type Organic Semiconductors

  摘要：

  Quaterthiophenes 4T, Oct-4T, and Tol-4T based on a central 2,2'-bithiophene core alpha,omega,-terminated with 4,4-unsubstituted and 4,4-disubstituted n-octyl or p-tolyl indeno[1,2-b]thiophene have been synthesized by Stille or Miyaura-Suzuki couplings. Compound 4T was also synthesized by an alternative route involving a soluble precursor bearing solubilizing trimethylsilyl groups which have been eliminated in the last step. The electronic properties of the compounds have been analyzed by cyclic voltammetry, UV-vis absorption and fluorescence emission spectroscopy. Thermal evaporation of 4T and Oct-4T leads to crystalline thin films and UV-vis absorption and X-ray diffraction data for these films suggest that the molecules adopt a quasi-vertical orientation onto the substrate. Strong pi-pi intermolecular interactions have been observed for 4T but not for molecules Oct-4T due to the presence of n-octyl chains. Sublimed thin films of Tol-4T show an amorphous character. The characterization of field-effect transistors fabricated from these three materials gave a hole-mobility of 2.2 x 10(-2) cm(2) V-1 s(-1) with an on/off ratio of 2.2 x 10(4) for 4T while no field-effect was observed for Oct-4T and Tol-4T.

  DOI：

  10.1021/jo802028n
• 作为产物：
  描述：

  2-(methoxycarbonyl)benzenediazonium tetrafluoroborate 在 五氯化磷 、 potassium acetate 、 sodium hydroxide 作用下， 以 乙醇 、 甲苯 、 乙腈 为溶剂， 反应 31.0h， 生成 2-(2-噻吩基)苯甲酰氯
  参考文献：
  名称：

  邻(5-甲酰基-2-噻吩基)苄腈和邻(5-甲酰基-2-呋喃基)苄腈的简单高效大规模无金属合成

  摘要：

  含有联芳基序的有机分子构成了一类重要的有机化合物。许多是天然来源的，例如抗生素万古霉素。其他是治疗高血压的有价值的药物。一些含有联芳基的药物包括缬沙坦、氯沙坦、厄贝沙坦及其同系物。它们是当今处方最多的药物之一。在上个世纪，芳基-芳基键的形成一直是许多论文的主题，并且可以使用几种有效的联芳合成方法，例如 Ullmann、Suzuki-Miyaura 和 Negishi 反应。关于我们发现具有噻吩基-芳基和呋喃基-芳基结构特征的候选药物的开发项目，我们需要简单有效的方法来大规模合成 o-(5-formyl-2-thienyl) benzonitrile 和 o-(5-formyl-2furyl)benzonitrile。目前，报道的制备这些目标化合物或相应中间体邻-(2-噻吩基)苄腈和邻-(2-呋喃基)苄腈的方法采用来自各自有机锡试剂、锰催化氧化交叉的Stille偶联。格氏试剂的偶联、钯催化的

  DOI：

  10.1080/00304948.2018.1405334

文献信息

• [EN] FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES CONDENSÉS EN TANT QUE MODULATEURS DE RÉCEPTEUR D'OREXINE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2011050202A1

  公开（公告）日：2011-04-28

  Certain disubstituted 3,8-diaza-bicyclo[4.2.0]octane and 3,6-diazabicyclo [3.2.0]heptane are described, which are useful as orexin inhibitors. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.

  某些二取代的3,8-二氮杂双环[4.2.0]辛烷和3,6-二氮杂双环[3.2.0]庚烷被描述为俄雷昔蛋白抑制剂。这些化合物可能在制药组合物和治疗由俄雷昔蛋白活性介导的疾病状态、紊乱和病况的方法中有用，比如失眠。
• SUBSTITUTED 7-AZABICYCLES AND THEIR USE AS OREXIN RECEPTOR MODULATORS
  申请人：COATE Heather R.

  公开号：US20160046640A1

  公开（公告）日：2016-02-18

  The present invention is directed to compounds of Formula I: wherein ring A is phenyl, naphihalenyl, pyridyl, quinolinyl, isoquinolinyl, imidazopyridyl, furanyi, tlisazolyl, isoxazolvl, pyrazolyl, imidazothiazolyi, benzimidazolyl, or indazolyi; R 1 is H, alky], aikoxy, hydroxyalkylene, OH, halo, phenyl, triazolyl, oxazolyl, isoxazofyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazmyl, piperazinyl, pyrazolyl, oxadiazolvl, pyrrolidinyl, thiophenyi, morpholinyl, or dialkyiamino; R 2 is H, alkyl, aikoxy, hydroxyalkylene, or halo; Z is NH, N-alkyl, or O; R 5 is pyridyl, pyrimidinyl, pyrazinyl, pyridazmyl, qumazolinyi, quinoxalinyl, pyrazolyl, benzoxazolyl, imidazopyrazinyl, triazolopyrazinyl, optionally substituted with a one or two substituents independently selected from the group consisting of alkyl, aikoxy, or halo; and n is 0 or 1, Methods of making the compounds of Formula 1 are also described. The invention also relates to pharmaceutical compositions comprising compounds of Formula I. Methods of using the compounds of the invention are also within the scope of the invention.

  本发明涉及式I的化合物：其中环A为苯基、萘基、吡啶基、喹啉基、异喹啉基、咪唑吡啉基、呋喃基、噻唑基、异噁唑基、吡唑基、咪唑噻唑基、苯并咪唑基或吲哚基；R1为H、烷基、烷氧基、羟基烷基、OH、卤素、苯基、三唑基、噁唑基、异噁唑基、吡啶基、嘧啶基、吡嗪基、吡啶并嗪基、哌嗪基、吡唑基、噁二唑基、吡咯烷基、噻吩基、吗啉基或二烷氨基；R2为H、烷基、烷氧基、羟基烷基或卤素；Z为NH、N-烷基或O；R5为吡啶基、嘧啶基、吡嗪基、吡啶并嗪基、喹唑啉基、喹喹啉基、吡唑基、苯并噁唑基、咪唑吡嗪基、三唑咪唑基，可选地取代一个或两个独立选择自烷基、烷氧基或卤素的基团；n为0或1，还描述了制备式I化合物的方法。本发明还涉及包含式I化合物的药物组合物。本发明还涉及使用该化合物的方法。
• Substituted Azabicyclo[2.2.1]heptanes as Selective Orexin-1 Antagonists: Discovery of JNJ-54717793
  作者：Cathy Préville、Pascal Bonaventure、Tatiana Koudriakova、Brian Lord、Diane Nepomuceno、Michele Rizzolio、Neelakandha Mani、Kevin J. Coe、Anthony Ndifor、Christine Dugovic、Curt A. Dvorak、Heather Coate、Daniel J. Pippel、Anne Fitzgerald、Brett Allison、Timothy W. Lovenberg、Nicholas I. Carruthers、Brock T. Shireman

  DOI：10.1021/acsmedchemlett.0c00085

  日期：2020.10.8

  nonselective substituted azabicyclo[2.2.1]heptane dual orexin receptor antagonist (DORA) into orally bioavailable, brain penetrating, selective orexin-1 receptor (OX1R) antagonists. This resulted in the discovery of our first candidate for clinical development, JNJ-54717793.

  食欲素系统由两种神经肽（食欲素-A和食欲素-B）组成，它们对两种受体（食欲素-1和食欲素-2）发挥作用。虽然orexin-2 受体的作用被确立为睡眠觉醒状态的重要调节剂，但orexin-1 受体的作用被认为在成瘾、恐慌或焦虑中起作用。在这份手稿中，我们描述了将非选择性取代的氮杂双环 [2.2.1] 庚烷双食欲素受体拮抗剂 (DORA) 优化为口服生物可利用的、脑穿透性的、选择性的食欲素-1 受体 (OX1R) 拮抗剂。这导致我们发现了我们的第一个临床开发候选者，JNJ-54717793。
• ZnI2-Catalyzed Cyanation of Acyl Chlorides with TMS-CN: An Interesting Role of Iodine
  作者：Wei Zeng、Jingya Yang、Bo Meng、Bo Zhang、Mingzhe Jiang、Fu-Xue Chen

  DOI：10.2174/157017809790442916

  日期：2009.12.1

  Both aliphatic and aromatic acyl cyanides have been synthesized with TMSCN and acyl chloride with ZnI2 (0.5 mol%). However the in situ generated I2 is proposed accounting for the formation of by-product O-TMS enolate at high catalyst loading rather than 0.5 mol%. Asymmetric reduction of benzoyl cyanide with borane has been explored in 82% yield and 24% ee.

  脂族和芳族酰基氰都与TMSCN合成，酰氯与ZnI2（0.5摩尔％）合成。然而，提出了原位产生的I 2，其解释了在高催化剂负载而不是0.5mol％的情况下副产物O-TMS烯醇化物的形成。研究了以硼烷不对称还原苯甲酰氰化物，产率为82％，ee为24％。
• Azonafide Derivatives, Methods for Their Production and Pharmaceutical Compositions Therefrom
  申请人：Van Quaquebeke Eric

  公开号：US20080292585A1

  公开（公告）日：2008-11-27

  Azonafide derivatives are obtained by reacting azonafide with aldehydes, acyl halides, thioacyl halides, monoisocyanates, isothiocyanates, sulfonyl halides, monohalogenoalkanes, monohalogenoalkenes or monohalogenoalkynes, and are useful as active ingredients of pharmaceutical compositions for the prevention and treatment of cell proliferative disorders, in particular several forms of Cancer.

  Azonafide衍生物是通过将azonafide与醛类、酰卤、硫酰卤、单异氰酸酯、异硫氰酸酯、磺酰卤、单卤代烷烃、单卤代烯烃或单卤代炔烃反应得到的，并且它们可用作制药组合物的活性成分，用于预防和治疗细胞增殖性疾病，特别是几种癌症。